IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics

IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics

Though efficacious in managing chronic, severe pain, opioid analgesics are accompanied by significant adverse effects including constipation, tolerance, dependence, and respiratory depression. The life-threatening risks associated with µ opioid receptor agonist-based analgesics challenges their use...

Full description

Bibliographic Details
Main Authors:	Kyle J. Rehrauer, Christopher W. Cunningham
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Pharmacological Research
Subjects:	Analgesics Drug design Drug discovery Opioid Bivalent ligand Bifunctional ligand
Online Access:	http://www.sciencedirect.com/science/article/pii/S1043661823003225

Similar Items

Synthesis and biological evaluation of a peptide-remifentanil conjugate as a novel bifunctional mu/delta-opioid receptor agonist for the treatment of pain
by: Lu Wang, et al.
Published: (2023-08-01)

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
by: Adriano Mollica, et al.
Published: (2017-01-01)

Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
by: Kathryn E Livingston, et al.
Published: (2018-06-01)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
by: Keith M. Olson, et al.
Published: (2023-07-01)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
by: Ing-Kang Ho, et al.
Published: (2013-10-01)

Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity
by: Thomas A. Munro, et al.
Published: (2013-12-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

5-Nitroisoxazoles in <i>S<sub>N</sub>Ar</i> Reactions: A Novel Chemo- and Regioselective Approach to Isoxazole-Based Bivalent Ligands of AMPA Receptors
by: Dmitry A. Vasilenko, et al.
Published: (2023-11-01)

Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands
by: Hui Zhong, et al.
Published: (2024-01-01)

Editorial: New approaches for the discovery of GPCR ligands
by: Paula Morales, et al.
Published: (2023-08-01)

Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
by: Sina B Kirchhofer, et al.
Published: (2023-11-01)

A bivalent glycopeptide to target two putative carbohydrate binding sites on FimH
by: Thisbe K. Lindhorst, et al.
Published: (2010-08-01)

Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross‐sectional study
by: Frank Moriarty, et al.
Published: (2022-02-01)

Clinically important drug interactions with opioid and non-opioid analgesics
by: Vezmar-Kovačević Sandra, et al.
Published: (2019-01-01)

Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges
by: Joanna Starnowska-Sokół, et al.
Published: (2020-11-01)

A Facile Approach to Bis(isoxazoles), Promising Ligands of the AMPA Receptor
by: Dmitry A. Vasilenko, et al.
Published: (2021-10-01)

Low opioid and opioid-free anesthesia - a review of current data
by: Dorota Czeremańska-Koczkodaj, et al.
Published: (2024-01-01)

A national study on the use of opioid analgesics in dentistry
by: Patrícia Azevedo LINO, et al.

Editorial: Interactions Between Small Molecule Ligands and Target Enzymes
by: Sung-Kun Kim, et al.
Published: (2021-03-01)

Non-opioid analgesics in contemporary treatment of pain
by: Tomić Maja, et al.
Published: (2019-01-01)

Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
by: Shaherin Basith, et al.
Published: (2018-03-01)

Pharmacotherapy of cancer pain with opioid analgesics
by: Krtinić Dane A., et al.
Published: (2023-01-01)

Structural requirements for ligands of the δ-opioid receptor
by: VUK I. MIĆOVIĆ, et al.
Published: (2009-11-01)

Structural requirements for ligands of the δ-opioid receptor
by: Mićović Vuk I., et al.
Published: (2009-01-01)

WAYS TO OPTIMIZE THE SYSTEM OF REALIZATION OPIOID ANALGESICS BY PRESCRIPTION THROUGH PHARMACIES
by: N.O. Datsiuk, et al.
Published: (2016-09-01)

Modeling the ligand specific m- and d-opioid receptor conformations
by: MILAN SENĆANSKI, et al.
Published: (2011-09-01)

MTLD, a Database of Multiple Target Ligands, the Updated Version
by: Chao Chen, et al.
Published: (2017-09-01)

Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide
by: Yangmei Li, et al.
Published: (2023-11-01)

SSnet: A Deep Learning Approach for Protein-Ligand Interaction Prediction
by: Niraj Verma, et al.
Published: (2021-01-01)

Ligand design for G protein-coupled receptors /
by: Rognan, Didier
Published: (2006)

Caffeine as an opioid analgesic adjuvant in fibromyalgia
by: Scott JR, et al.
Published: (2017-07-01)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
by: Jie Dong, et al.
Published: (2023-12-01)

Dissimilar Ligands Bind in a Similar Fashion: A Guide to Ligand Binding-Mode Prediction with Application to CELPP Studies
by: Xianjin Xu, et al.
Published: (2021-11-01)

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
by: Aleša Bricelj, et al.
Published: (2021-07-01)

A brief review of protein–ligand interaction prediction
by: Lingling Zhao, et al.
Published: (2022-01-01)

IUPHAR review – Data-driven computational drug repurposing approaches for opioid use disorder
by: Zhenxiang Gao, et al.
Published: (2024-01-01)

Structural Insights into σ1 Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations
by: Mateusz Kurciński, et al.
Published: (2018-02-01)

Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis
by: David G. Lambert
Published: (2023-06-01)

Monitoring drug promiscuity over time [v1; ref status: indexed, http://f1000r.es/4bh]
by: Ye Hu, et al.
Published: (2014-09-01)

Monitoring drug promiscuity over time [v2; ref status: indexed, http://f1000r.es/4oa]
by: Ye Hu, et al.
Published: (2014-11-01)